Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33526514 | 0.69 | RIPK1 (0.34) | MAOAMAOB | |
| SCHEMBL13932290 | 0.60 | PARP1 (0.50) | MAOAMAOB | |
| SCHEMBL33526277 | 0.59 | MAOA (0.36) | MAOAMAOB | |
| SCHEMBL19153122 | 0.58 | MAOA (0.41) | MAOAMAOB | |
| SCHEMBL33526483 | 0.58 | MAOA (0.38) | MAOAMAOB | |
| SCHEMBL33526792 | 0.58 | ABCC9 (0.42) | MAOAMAOB | |
| SCHEMBL13021607 | 0.57 | MAOA (0.49) | MAOAMAOB | |
| SCHEMBL9959163 | 0.57 | MAOA (0.53) | MAOAMAOB | |
| SCHEMBL31659495 | 0.57 | TDP2 (0.47) | MAOAMAOB | |
| SCHEMBL626215 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | MAOA 3712/4885MAOB 3194/4885KAT6A 3025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.